William E. Weiser (Bill), President of Techlytic Consulting, is recognized for his ability to lead drug development projects as well as large contract analytical chemistry laboratories.
unique talents in pharmaceutical analysis and drug development are supported by his
strengths in leadership, problem solving, communication, and team-based cultures.
Bill's expertise stems from 18 years of experience in the pharmaceutical industry.
Prior to establishing Techlytic Consulting, he was Vice President Analytical Chemistry at Cardinal Health Pharmaceutical Development, where he led a 100-scientist contract Analytical Chemistry Laboratory.
contributed to the six-fold growth of Magellan Laboratories (acquired by Cardinal Health
in 2002) over a seven-year period.
provided leadership to cultivate clients, build laboratories, hire staff, establish operational systems, and execute high-quality analytical services.
Prior to coming to Magellan, Bill
had a nine year career at Burroughs Wellcome Co.
As an International Technical Development Coordinator, he provided matrix management of five technical CMC teams, which included synthetic, analytical, and formulation development scientists.
His experience also included analytical chemistry support for IND stage APIs.
He has a Ph.D. in Analytical Chemistry from Purdue University, and a B.S. in Chemistry from The College of William and Mary.
has attended executive programs at UNC-Chapel Hill, Ohio State University
, and the Center for Creative Leadership at the University of Maryland